Craig-Hallum analyst Albert Lowe initiated coverage of SAB Biotherapeutics with a Buy rating and $11 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SABS:
Craig-Hallum analyst Albert Lowe initiated coverage of SAB Biotherapeutics with a Buy rating and $11 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SABS: